🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the side effects of panobinostat nanoparticle...
Status
Completed
Location
University of California, San Francisco
Start Date
2018-05-22
Trial ID
NCT03566199
Treatments Being Tested
The purpose of the study is to find out the effects and the safety of an in...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2010-03
Trial ID
NCT01090973
Treatments Being Tested
This study will evaluate the efficacy and safety of LBH589B in adult patien...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2007-02-19
Trial ID
NCT00451035
Treatments Being Tested
This study comprises of a dose-escalation and dose expansion phase and will...
Status
Completed
Location
Innovative Medical Research of South Florida Dept.ofInnovativeMedResearch
Start Date
2007-10
Trial ID
NCT00532389
Treatments Being Tested
This study will evaluate the efficacy and safety of LBH589B in adult patien...
Status
Terminated
Location
City of Hope National Medical Center
Start Date
2007-02-23
Trial ID
NCT00449761
Treatments Being Tested
This study will assess safety as well as establish a Recommended Phase II d...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-11-01
Trial ID
NCT01433445
Treatments Being Tested
RATIONALE: Panobinostat and imatinib mesylate may stop the growth of cancer...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-05
Trial ID
NCT00686218
The purpose of this study was to combine the PDR001 checkpoint inhibitor wi...
Status
Completed
Location
UCLA Santa Monica Hematology / Oncology SC
Start Date
2016-10-14
Trial ID
NCT02890069
Treatments Being Tested
The purpose of this study is to treat metastatic melanoma with a combinatio...
Status
Terminated
Location
University of Iowa Hospitals and Clinics
Start Date
2009-12
Trial ID
NCT00925132
Treatments Being Tested
The primary purpose of this open-label study is to investigate the interact...
Status
Completed
Location
Nevada Cancer Institute
Start Date
2007-09
Trial ID
NCT00503451
Treatments Being Tested